M&A Activity Surges 22% in 2026 as Companies Hunt for Growth via Acquisitions

Global merger and acquisition (M&A) deal value reached $1.8 trillion in the first half of 2026, a 22% increase compared to the same period in 2025, according to data from Refinitiv. The number of deals also rose 14% to 12,400 transactions, signaling robust corporate appetite for inorganic growth despite higher borrowing costs and economic uncertainty.

Technology, healthcare, and energy sectors accounted for nearly 60% of total deal value, as companies leverage strong balance sheets and cash reserves to acquire innovative startups, expand market share, and consolidate fragmented industries.

Key Takeaways for Investors and Executives

• Total H1 2026 M&A value: $1.8 trillion, up 22% from $1.47 trillion in H1 2025.
• Deal count: 12,400, a 14% increase from 10,900 in the prior-year period.
• Average deal size rose to $145 million, compared to $135 million in 2025, reflecting a shift toward larger strategic acquisitions.
• Cross-border deals represented 38% of total value, up from 34%, as multinationals seek geographic diversification and access to new markets.
• Private equity participation jumped 31%, with buyout funds deploying record dry powder of $1.2 trillion.

What Industries Are Driving M&A Growth in 2026?

Three sectors dominate the M&A landscape: technology, healthcare, and energy. Technology deals alone reached $620 billion, fueled by AI, cloud computing, and cybersecurity acquisitions. Healthcare M&A hit $410 billion, driven by biotech innovation and aging population demographics. Energy and natural resources saw $280 billion in deals, as oil and gas companies consolidate and renewable energy firms scale up.

Other sectors like financial services, industrials, and consumer goods also saw notable activity, but at lower growth rates.

Sector-by-Sector Breakdown of H1 2026 M&A Activity

Why Are Companies Pursuing M&A Despite Higher Interest Rates?

With the Federal Reserve holding rates at 5.25%-5.50% and borrowing costs elevated, many expected M&A to cool. Instead, activity accelerated. Corporate balance sheets remain strong, with S&P 500 companies holding over $2.3 trillion in cash, much of it deployed for acquisitions. Additionally, strategic buyers are using stock as currency, with equity valuations supporting attractive swap ratios.

Private equity firms are also active, leveraging their massive dry powder ($1.2 trillion) and using creative financing structures to bridge the cost-of-capital gap. Many PE firms are targeting add-on acquisitions to build platforms and drive operational efficiencies.

Furthermore, technological disruption and regulatory changes are forcing companies to buy rather than build. In AI and biotech, the pace of innovation makes internal development too slow, so acquisitions are the fastest route to market.

How Does This Affect Small Businesses and Startups?

For startups, the M&A boom presents both opportunities and risks. On the positive side, acquisition premiums have risen, with average takeover multiples at 12.5x EBITDA, up from 11.2x in 2025. This creates attractive exit avenues for founders and early investors.

However, increased consolidation can reduce competition and make it harder for smaller players to compete against larger combined entities. Regulators are scrutinizing deals more closely, especially in tech and healthcare, with the U.S. Department of Justice and FTC blocking or challenging several large transactions in 2026.

Small businesses may also face supply chain shifts and changed customer dynamics as larger competitors absorb key suppliers or distributors.

Regulatory Challenges and Antitrust Scrutiny in 2026

Antitrust enforcement has intensified, with U.S. and EU regulators adopting tougher stances. In the U.S., the FTC has filed lawsuits to block three major tech deals totaling $48 billion, citing competition concerns. In Europe, the European Commission has opened in-depth investigations into healthcare and energy mergers, delaying some transactions.

Despite this, dealmakers are finding ways to navigate regulatory hurdles through divestitures, behavioral remedies, and structuring deals as asset purchases rather than full mergers. The approval rate for notified deals remains above 90%, but timelines have extended from an average of 4 months to 6 months.

What Does This Mean for Investors?

Investors are rewarded in M&A-driven markets, as target companies often see double-digit share price jumps upon announcement. However, acquirer stocks tend to underperform in the short term due to integration risks and premium paid. Over the long term, successful acquirers generate superior returns, but only if they execute integration well.

Analysts recommend focusing on sectors with high fragmentation and consolidation potential, such as healthcare IT, cybersecurity, and renewable energy. Additionally, monitoring regulatory developments and deal financing structures can provide clues to future trends.

Outlook for H2 2026 and Beyond

Most investment banks project full-year M&A value to exceed $3.5 trillion, potentially reaching $3.8 trillion if current momentum holds. Key catalysts include the U.S. election outcomes, potential tax policy changes, and further interest rate adjustments. The dry powder overhang and strategic imperative for digital transformation will likely sustain activity into 2027.

However, risks include geopolitical tensions, supply chain disruptions, and a potential economic slowdown. Dealmakers are pricing in a soft landing scenario, but any recessionary shock could freeze transactions.

Frequently Asked Questions (FAQ)

What is driving the surge in M&A activity in 2026?

Record cash reserves, strategic needs to acquire AI and healthcare capabilities, and private equity dry powder are the main drivers. Companies are also seeking scale to combat inflation and supply chain volatility, making acquisitions attractive despite high interest rates.

Which sectors are hottest for M&A right now?

Technology, healthcare, and energy lead the pack. Tech focuses on AI and cybersecurity, healthcare on biotech and digital health, and energy on both fossil fuel consolidation and renewable scale-up.

How are high interest rates affecting deal financing?

Higher rates increase borrowing costs, but acquirers are using cash reserves, stock swaps, and seller financing to reduce reliance on debt. Many deals are structured with earn-outs and contingent value rights to bridge valuation gaps.

Should startup founders consider selling now?

With elevated multiples and strong buyer demand, 2026 is a favorable exit window. However, founders should weigh long-term growth prospects against immediate gains and consult with financial advisors to time the market effectively.